Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 159.27M P/E - EPS this Y 17.40% Ern Qtrly Grth -
Income -43.27M Forward P/E -3.05 EPS next Y -1.60% 50D Avg Chg -17.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -30.00%
Dividend N/A Price/Book 7.30 EPS next 5Y - 52W High Chg -69.00%
Recommedations 3.00 Quick Ratio 1.45 Shares Outstanding 54.92M 52W Low Chg 143.00%
Insider Own 43.25% ROA -80.82% Shares Float 22.51M Beta 1.21
Inst Own 4.50% ROE -257.84% Shares Shorted/Prior 1.11M/1.54M Price 4.39
Gross Margin - Profit Margin - Avg. Volume 243,537 Target Price 11.00
Oper. Margin - Earnings Date May 8 Volume 75,128 Change -3.09%
About BioVie Inc.

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

BioVie Inc. News
04/29/24 BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID
04/25/24 BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
04/18/24 BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
04/12/24 Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
03/12/24 Bears are Losing Control Over BioVie Inc. (BIVI), Here's Why It's a 'Buy' Now
03/11/24 BioVie Announces Pipeline Update and Near-Term Clinical Priorities
03/06/24 BioVie Inc. Announces Closing of Public Offering
03/04/24 BioVie Inc. Announces Pricing of Public Offering
03/01/24 BioVie Inc. Announces Proposed Public Offering of Common Stoc
03/01/24 BioVie Inc. Announces Proposed Public Offering of Common Stock
03/01/24 BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
02/06/24 BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
01/27/24 18 Best 52-Week Low Stocks To Buy Now
01/05/24 bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
12/29/23 Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
12/22/23 Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
12/11/23 BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
12/01/23 The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
10:33 AM Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
10:20 AM BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study Data
BIVI Chatroom

User Image Market_Max Posted - 1 day ago

$SAVA The companies who have always appeared to be "Me-too" in the AD space, are all dropping dead now... $BIVI, $CRTX, $AVXL and now $ANVS. I saw through the BS of all of these...I was in all of these at one point or the other (in addition to being in $SAVA)..but over time, I was able to cut out of all of them when it started to appear to me who the clear choice should be for me. While cutting out of all of these me-toos, I have built a solid count of my shares in $SAVA - the clear choice!

User Image urgetosurge Posted - 1 day ago

$BIVI Still isn't enough to momo the stock mc? Wow..

User Image FullSail Posted - 1 day ago

$BIVI All I want to know is, Did Pelosi invest in this?

User Image pocketmoney Posted - 1 day ago

$BIVI $13.1 mil award from DOD

User Image G101SPM Posted - 1 day ago

$BIVI $0.52 bid. DAC $0.6775. EXIT $3.00. NEWS: BIOVIE AWARDED UP TO $13.1 MILLION IN FUNDING FROM U.S. DEPARTMENT OF DEFENSE TO EVALUATE BEZISTERIM (NE3107) FOR THE TREATMENT OF LONG COVID.

User Image tanku2much Posted - 1 day ago

$BIVI Bezisterim attracting interest in a new clinical trial is bullish. DOD has faith in BIVI's ability to execute a clinical trial.

User Image DonCorleone77 Posted - 1 day ago

$BIVI BioVie awarded up to $13.1M in funding from U.S. DOD to evaluate bezisterim BioVie announced the grant of a clinical trial award of up to $13.1 million from the U.S. Department of Defense, DOD, awarded through the Peer Reviewed Medical Research Program, PRMRP, of the Congressionally Directed Medical Research Programs, CDMRP. The award can provide up to 2 years of non-dilutive funding for a Phase 2b clinical trial that will assess the Company's anti-inflammatory and insulin sensitizer candidate, bezisterim, for the treatment of neurological symptoms that are associated with long COVID. The Company anticipates the trial to commence by early 2025.

User Image stockalertsdaily Posted - 1 day ago

Picks for week $izm $xfor $bivi

User Image RETAlerts Posted - 1 day ago

$BIVI at 0.545 just landed on our momentum scanner, make sure it's on your watch list and as always, get your edge! (15 minute delay)

User Image Stock_Titan Posted - 1 day ago

$BIVI BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID https://www.stocktitan.net/news/BIVI/bio-vie-awarded-up-to-13-1-million-in-funding-from-u-s-department-of-brrp23z5ktet.html

User Image tushal1980 Posted - 4 days ago

$BIVI who the fuck is this guy with snake oil what does really mean he needs oil to rub him or what guys any idea plz and thanks

User Image TJ12000 Posted - 4 days ago

$BIVI prove me wrong do Kong about my snake oil theory… I really hope to apologize for thinking u a snake oil distributor.

User Image TJ12000 Posted - 4 days ago

$BIVI Kong knows the path! Don’t hold ur breath

User Image doyoujetset Posted - 4 days ago

$BIVI the final flush setup into a b shaped weekly volume profile. Sideways consolidation with new POC line setup to fill upwards to the next volume node💣📈

User Image TradeMadeNow Posted - 5 days ago

$BIVI $IBRX ... Let's make money together friends. Both of these beaten down baby bios have the potential to run.

User Image TJ12000 Posted - 5 days ago

$BIVI donkey decides to change snake yet again….from snake 🐍 oil to 🪲 beetle juice!!

User Image G101SPM Posted - 5 days ago

$BIVI $0.4925 bid. DAC (4) 0.6775. EXIT $3.00. Note: SPM 81.26 tag (134 bits increase) was due to: Today's announced that an oral presentation and poster revealing additional data on how bezisterim potentially restores homeostasis was presented at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit held in Boston, Massachusetts April 23-25. The data presented were based on further analysis of data generated from Phase 3 trial in Alzheimer's disease (AD) that was unblinded at the end of 2023. The DNA methylation dataset assessed the extent of DNA methylation on roughly 965,000 individual sites where methyl groups can be attached to the patients' DNA. "... {D]ata provide evidence that bezisterim may have the potential to help keep people healthier for a longer time as we age," said Cuong Do, BioVie's(BIVI) President and CEO. " Bezisterim is believed to be the first drug candidate that has shown in clinical trials the ability to modulate the level of DNA methylation.

User Image G101SPM Posted - 5 days ago

$BIVI $0.4905 bid. BUY/ADD TO POSITION with SPM 81.26 tag to EXIT at $3.00. DAC (4) $0.6775.

User Image TJ12000 Posted - 5 days ago

$BIVI Bezisterim (NE3107) is the breaking news for this scam?! Bamboozled would be a better name

User Image YoloAlfred Posted - 5 days ago

$BIVI 🤔🤔🤔🤔🤔🤔

User Image Stock_Titan Posted - 5 days ago

$BIVI BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints https://www.stocktitan.net/news/BIVI/bio-vie-presents-data-showing-potential-for-bezisterim-ne3107-to-yt8lgbihirpa.html

User Image TJ12000 Posted - 6 days ago

$BIVI Kong release news that NE3107 improves baldness… stock is ready to rocket!!

User Image TJ12000 Posted - 6 days ago

$BIVI what kind of fake news did the donkey release?! No change in pathetic price of this snake oil

User Image AVCTQBNAPL Posted - 6 days ago

$BIVI It's show time! 🤑🤑🤑

User Image TradeMadeNow Posted - 6 days ago

$BIVI Slowly getting some traction here...

User Image RallyRaider Posted - 6 days ago

$BIVI trying some off the bottom

User Image urgetosurge Posted - 6 days ago

$BIVI volumes in play and a pre run staging??

User Image TJ12000 Posted - 6 days ago

$BIVI snake oil scam

User Image RETAlerts Posted - 1 week ago

$BIVI at 0.514 just landed on our momentum scanner, make sure it's on your watch list and as always, get your edge! (15 minute delay)

User Image TJ12000 Posted - 1 week ago

$BIVI do Kong …pound sand u dope

Analyst Ratings
Oppenheimer Outperform Nov 30, 23
Cantor Fitzgerald Overweight Aug 22, 23
Cantor Fitzgerald Overweight Jul 18, 23
Cantor Fitzgerald Overweight May 17, 23
Oppenheimer Outperform May 17, 23
Oppenheimer Outperform Feb 14, 23
EF Hutton Buy Sep 28, 22
Cantor Fitzgerald Overweight Jul 22, 22
EF Hutton Buy Mar 17, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DO CUONG V President & CEO President & CEO Nov 30 Buy 1.78 10,000 17,800 68,759 12/01/23
GORLIN STEVE Director Director Sep 05 Sell 3.05 8,560 26,108 75,680 09/07/23
BERMAN RICHARD J Director Director Aug 22 Sell 3.5009 10,805 37,827 16,789 08/24/23
BERMAN RICHARD J Director Director May 22 Sell 6.16 10,984 67,661 23,210 06/15/23
BERMAN RICHARD J Director Director Mar 27 Sell 8.52 10,984 93,584 34,194 04/06/23